S

Sarepta Therapeutics
D

SRPT

120.200
USD
-5.63
(-4.47%)
مغلق
حجم التداول
22,220
الربح لكل سهم
2
العائد الربحي
-
P/E
78
حجم السوق
11,481,461,930
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    BIIB
    BIIB
    -3.790
    (-2.52%)
    146.820 USD
    B
    BLUE
    -0.51500
    (-5.75%)
    8.44000 USD
    C
    CRSP
    -3.490
    (-7.83%)
    41.110 USD
    E
    EDIT
    -0.17500
    (-11.51%)
    1.34500 USD
    GILD
    GILD
    -2.130
    (-2.30%)
    90.630 USD
    I
    IONS
    -1.430
    (-3.79%)
    36.260 USD
    REGN
    REGN
    -25.38
    (-3.43%)
    714.50 USD
    R
    RGLS
    -0.11000
    (-6.79%)
    1.51000 USD
    VRTX
    VRTX
    -21.90
    (-4.67%)
    447.46 USD
    المزيد
الأخبار

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.